Literature DB >> 15941805

Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country.

Young Ae Kang1, Hye Won Lee, Ho Il Yoon, BeLong Cho, Sung Koo Han, Young-Soo Shim, Jae-Joon Yim.   

Abstract

CONTEXT: A recently developed whole-blood interferon gamma (IFN-gamma) assay based on stimulation with the Mycobacterium tuberculosis-specific antigens early secreted antigenic target 6 and culture filtrate protein 10 shows promise for the diagnosis of latent tuberculosis (TB) infection.
OBJECTIVE: To compare the tuberculin skin test (TST) and the whole-blood IFN-gamma assay in the diagnosis of latent TB infection according to the intensity of exposure. DESIGN AND
SETTING: A prospective comparison between the whole-blood IFN-gamma assay and the TST using a 2-TU dose of purified protein derivative RT23 in a population with intermediate TB burden was conducted sequentially between February 1, 2004, and February 28, 2005, in a Korean tertiary referral hospital. PARTICIPANTS: Of 273 participants, 220 (95.7%) had received BCG vaccine. Participants were grouped according to their risk of infection: group 1, no identifiable risk of M tuberculosis infection (n = 99); group 2, recent casual contacts (n = 72); group 3, recent close contacts (n = 48); group 4, bacteriologically or pathologically confirmed TB patients (n = 54). MAIN OUTCOME MEASURES: Levels of agreement between the TST and the IFN-gamma assay and the likelihood of infection in the various groups.
RESULTS: For the TST with a 10-mm induration cutoff, the positive response rate in group 1 was 51%; group 2, 60%; group 3, 71%, and group 4, 78%. For the IFN-gamma assay, the positive response rate in group 1 was 4%; group 2, 10%; group 3, 44%; and group 4, 81%. The overall agreement between the TST and the IFN-gamma assay in healthy volunteers was kappa = 0.16. The odds of a positive test result per unit increase in exposure across the 4 groups increased by a factor of 5.31 (95% confidence interval [CI], 3.62-7.79) for the IFN-gamma assay and by a factor of 1.52 (95% CI, 1.20-1.91) for the TST (P<.001). Using a 15-mm induration cutoff for the TST did not make a substantial difference to the test results.
CONCLUSION: The IFN-gamma assay is a better indicator of the risk of M tuberculosis infection than TST in a BCG-vaccinated population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15941805     DOI: 10.1001/jama.293.22.2756

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  110 in total

1.  Evaluation of a tuberculosis whole-blood interferon-γ chemiluminescent immunoassay among Chinese military recruits.

Authors:  Xueqiong Wu; Ying Hou; Yan Liang; Junxian Zhang; Yourong Yang; Lan Wang; Chuiying Zhang
Journal:  Mol Diagn Ther       Date:  2011-12-01       Impact factor: 4.074

2.  Utilization of the QuantiFERON-TB Gold test in a two-step process with the tuberculin skin test to evaluate health care workers for latent tuberculosis.

Authors:  Baha Abdalhamid; Steven H Hinrichs; Jodi L Garrett; Jean M O'Neill; Kristine M Hansen-Cain; Amy A Armbrust; Peter C Iwen
Journal:  J Clin Microbiol       Date:  2010-06-23       Impact factor: 5.948

Review 3.  Recent advances in testing for latent TB.

Authors:  Neil W Schluger; Joseph Burzynski
Journal:  Chest       Date:  2010-12       Impact factor: 9.410

4.  Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease.

Authors:  S A Clark; S L Martin; A Pozniak; A Steel; B Ward; J Dunning; D C Henderson; M Nelson; B Gazzard; P Kelleher
Journal:  Clin Exp Immunol       Date:  2007-08-02       Impact factor: 4.330

5.  Reproducibility of QuantiFERON-TB gold in-tube assay.

Authors:  Sharon Perry; Luz Sanchez; Shufang Yang; Zubin Agarwal; Philip Hurst; Julie Parsonnet
Journal:  Clin Vaccine Immunol       Date:  2008-01-16

6.  Differences in tuberculin reactivity as determined in a veterans administration employee health screening program.

Authors:  Sanjay R Mehta; Cathy MacGruder; David Looney; Scott Johns; Davey M Smith
Journal:  Clin Vaccine Immunol       Date:  2009-02-18

7.  Evaluation of an interferon gamma assay in the diagnosis of latent tuberculosis infection in patients with rheumatoid arthritis.

Authors:  Cláudia Diniz Lopes Marques; Ângela Luzia Branco Pinto Duarte; Virginia Maria Barros de Lorena; Joelma Rodrigues Souza; Wayner Vieira Souza; Yara de Miranda Gomes; Eduardo Maia Freese de Carvalho
Journal:  Rheumatol Int       Date:  2009-11       Impact factor: 2.631

8.  Trends in influenza vaccination coverage rates in Germany over six seasons from 2001/02 to 2006/07.

Authors:  Patricia R Blank; Andreas U Freiburghaus; Bernhard R Ruf; Matthias M Schwenkglenks; Thomas D Szucs
Journal:  Med Klin (Munich)       Date:  2009-01-23

9.  Risk factors for false-negative results of T-SPOT.TB and tuberculin skin test in extrapulmonary tuberculosis.

Authors:  Y-M Lee; K-H Park; S-M Kim; S J Park; S-O Lee; S-H Choi; Y S Kim; J H Woo; S-H Kim
Journal:  Infection       Date:  2013-08-14       Impact factor: 3.553

10.  Performance of an interferon-gamma release assay for diagnosing latent tuberculosis infection in children.

Authors:  K Okada; T E Mao; T Mori; T Miura; T Sugiyama; T Yoshiyama; S Mitarai; I Onozaki; N Harada; S Saint; K S Kong; Y M Chhour
Journal:  Epidemiol Infect       Date:  2007-11-08       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.